The EORTC Phase II study of iproplatin in advanced osteogenic sarcoma.
Pawinski
A
A
Crowther
D
D
Keizer
H J
HJ
Voûte
P A
PA
Somers
R
R
van Glabbeke
M
M
Lentz
M A
MA
van Oosterom
A T
AT
D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000627:therapeutic use*; D012516:Osteosarcoma / Q000188:drug therapy*
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; C023359:iproplatin